Modulation of Neurturin Expression by Lumbosacral Spinal Stenosis, Lifestyle Factors, and Glycemic Dysregulation

<b>Background/Objectives</b>: Lumbosacral spinal stenosis (LSS) is a degenerative condition characterized by narrowing of the spinal canal and associated neuropathic pain. While mechanical compression is well-characterized, the molecular mechanisms contributing to symptom severity remain poorly understood. Neurturin (NRTN), a member of the glial cell line-derived neurotrophic factor family, has emerged as a potential mediator of neural plasticity and nociception, but its role in spinal stenosis is largely unexplored. <b>Methods</b>: We analyzed <i>NRTN</i> mRNA and protein expression in ligamentum flavum samples from 96 patients undergoing surgery for LSS and 85 non-degenerative postmortem controls. Quantification was performed using real-time quantitative polymerase chain reaction (RT-qPCR), enzyme-linked immunosorbent assay (ELISA), Western blotting, and immunohistochemistry. Pain severity Visual Analog Scale (VAS), body mass index (BMI), diabetes, smoking, and alcohol use were assessed as modulators of NRTN expression. <b>Results</b>: NRTN expression was significantly elevated in LSS patients versus controls at both transcript and protein levels (<i>p</i> < 0.05). NRTN levels positively correlated with pain intensity (VAS; ANOVA <i>p</i> = 0.032 for mRNA, <i>p</i> = 0.041 for protein). Multivariate regression identified BMI (β = 0.50, <i>p</i> = 0.015) and diabetes (β = 0.39, <i>p</i> = 0.017) as independent predictors of increased NRTN expression. Alcohol use also showed a positive association (<i>p</i> = 0.046), while smoking showed no significant independent effect. <b>Conclusions</b>: Neurturin is upregulated in ligamentum flavum tissue from LSS patients and correlates with pain severity and metabolic risk factors. These findings suggest NRTN as a potential biomarker and therapeutic target in degenerative spine disease. Further longitudinal and mechanistic studies are warranted to elucidate its role in chronic pain and neuroinflammation.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2025-05-01
DOI
https://doi.org/10.3390/biomedicines13051102
Citations
2
Primary Topic
Spine and Intervertebral Disc Pathology
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modulation of Neurturin Expression by Lumbosacral Spinal Stenosis, Lifestyle Factors, and Glycemic Dysregulation

Dawid Sobański, Beniamin Oskar Grabarek, Rafał Staszkiewicz, Paweł Gogol et al.
2 citations
Biomedicines
Spine and Intervertebral Disc Pathology
2.94
article

Modulation of Neurturin Expression by Lumbosacral Spinal Stenosis, Lifestyle Factors, and Glycemic Dysregulation

Dawid Sobański, Beniamin Oskar Grabarek, Rafał Staszkiewicz, Paweł Gogol, Werner Dammermann, Damian Strojny, Małgorzata Sobańska, Tomasz Pawłaszek
article en
2 citations

Abstract

<b>Background/Objectives</b>: Lumbosacral spinal stenosis (LSS) is a degenerative condition characterized by narrowing of the spinal canal and associated neuropathic pain. While mechanical compression is well-characterized, the molecular mechanisms contributing to symptom severity remain poorly understood. Neurturin (NRTN), a member of the glial cell line-derived neurotrophic factor family, has emerged as a potential mediator of neural plasticity and nociception, but its role in spinal stenosis is largely unexplored. <b>Methods</b>: We analyzed <i>NRTN</i> mRNA and protein expression in ligamentum flavum samples from 96 patients undergoing surgery for LSS and 85 non-degenerative postmortem controls. Quantification was performed using real-time quantitative polymerase chain reaction (RT-qPCR), enzyme-linked immunosorbent assay (ELISA), Western blotting, and immunohistochemistry. Pain severity Visual Analog Scale (VAS), body mass index (BMI), diabetes, smoking, and alcohol use were assessed as modulators of NRTN expression. <b>Results</b>: NRTN expression was significantly elevated in LSS patients versus controls at both transcript and protein levels (<i>p</i> < 0.05). NRTN levels positively correlated with pain intensity (VAS; ANOVA <i>p</i> = 0.032 for mRNA, <i>p</i> = 0.041 for protein). Multivariate regression identified BMI (β = 0.50, <i>p</i> = 0.015) and diabetes (β = 0.39, <i>p</i> = 0.017) as independent predictors of increased NRTN expression. Alcohol use also showed a positive association (<i>p</i> = 0.046), while smoking showed no significant independent effect. <b>Conclusions</b>: Neurturin is upregulated in ligamentum flavum tissue from LSS patients and correlates with pain severity and metabolic risk factors. These findings suggest NRTN as a potential biomarker and therapeutic target in degenerative spine disease. Further longitudinal and mechanistic studies are warranted to elucidate its role in chronic pain and neuroinflammation.

BiomedicinesVol. 13(5)
Cracow University of Technology (PL), Państwowa Akademia Nauk Stosowanych w Przemyślu (PL), 1 Military Clinical Hospital with Outpatient Clinic (PL), WSB University (PL), Medizinische Hochschule Brandenburg Theodor Fontane (DE), Universitätsklinikum Brandenburg an der Havel (DE)
Openalex Percentile: Top 10%
Spine and Intervertebral Disc Pathology
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.